Agile Therapeutics, Inc. (AGRX) Statistics & Valuation Metrics

Total Valuation

AGRX has a market cap or net worth of $4.90 million. The enterprise value is $4.19 million.

Market Cap	4.90M
Enterprise Value	4.19M

Important Dates

The last earnings date was Thursday, November 9, 2023, before market open.

Earnings Date	Nov 9, 2023
Ex-Dividend Date	n/a

Share Statistics

AGRX has 2.51 million shares outstanding. The number of shares has increased by 298.69% in one year.

Shares Outstanding	2.51M
Shares Change (YoY)	+298.69%
Shares Change (QoQ)	+66.69%
Owned by Insiders (%)	3.97%
Owned by Institutions (%)	5.95%
Float	2.51M

Valuation Ratios

The trailing PE ratio is 0.02 and the forward PE ratio is 2.53.

PE Ratio	0.02
Forward PE	2.53
PS Ratio	0.25
Forward PS	0.12
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.51
EV / Sales	0.21
EV / EBITDA	0.41
EV / EBIT	0.43
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.57

Current Ratio	0.57
Quick Ratio	0.36
Debt / Equity	n/a
Debt / EBITDA	0.21
Debt / FCF	n/a
Interest Coverage	6.33

Financial Efficiency

Return on equity (ROE) is -83.40% and return on invested capital (ROIC) is 221.65%.

Return on Equity (ROE)	-83.40%
Return on Assets (ROA)	64.10%
Return on Capital (ROIC)	221.65%
Revenue Per Employee	$907,909
Profits Per Employee	$374,636
Employee Count	22
Asset Turnover	1.55
Inventory Turnover	4.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.45% in the last 52 weeks. The beta is 1.84, so AGRX's price volatility has been higher than the market average.

Beta (1Y)	1.84
52-Week Price Change	-80.45%
50-Day Moving Average	2.03
200-Day Moving Average	3.75
Relative Strength Index (RSI)	44.36
Average Volume (30 Days)	46,869

Short Selling Information

The latest short interest is 8,313, so 0.33% of the outstanding shares have been sold short.

Short Interest	8,313
Short Previous Month	6,685
Short % of Shares Out	0.33%
Short % of Float	0.33%
Short Ratio (days to cover)	0.15

Income Statement

In the last 12 months, AGRX had revenue of $19.97 million and earned $8.24 million in profits. Earnings per share was $78.17.

Revenue	19.97M
Gross Profit	11.53M
Operating Income	-22.71M
Pretax Income	8.24M
Net Income	8.24M
EBITDA	10.17M
EBIT	9.79M
Earnings Per Share (EPS)	$78.17

Full Income Statement

Balance Sheet

The company has $2.87 million in cash and $2.16 million in debt, giving a net cash position of $709,000 or $0.28 per share.

Cash & Cash Equivalents	2.87M
Total Debt	2.16M
Net Cash	709,000
Net Cash Per Share	$0.28
Equity / Book Value	-12.41M
Book Value Per Share	-4.94
Working Capital	-7.47M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11.31M
Capital Expenditures	n/a
Free Cash Flow	-11.31M
FCF Per Share	-$3.83

Full Cash Flow Statement

Margins

Gross margin is 57.75%, with operating and profit margins of -113.71% and 41.26%.

Gross Margin	57.75%
Operating Margin	-113.71%
Pretax Margin	41.26%
Profit Margin	41.26%
EBITDA Margin	50.90%
EBIT Margin	49.01%
FCF Margin	-56.61%

Dividends & Yields

AGRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Earnings Yield	168.28%
FCF Yield	-230.88%
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Buyback Yield	-298.69%
Shareholder Yield	-298.69%

Analyst Forecast

The average price target for AGRX is $8.50, which is 335.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.50
Price Target Difference	335.90%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	57.12%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 11, 2023. It was a reverse split with a ratio of 1:50.

Last Split Date	Apr 11, 2023
Split Type	Reverse
Split Ratio	1:50

Scores

AGRX has an Altman Z-Score of -49.73 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-49.73
Piotroski F-Score	5